Dhaliwal Jasmeet S, Kaufman Stephen C
Hauser-Ross Eye Institute, Kish Health System, Sycamore, IL, USA.
Cornea. 2009 Jan;28(1):62-7. doi: 10.1097/ICO.0b013e31818225c3.
The purpose of this study was to evaluate morphological changes induced by corneal collagen cross-linking in a human ex vivo cornea, using confocal, electron, and light microscopy.
The central epithelium was partially removed from ex vivo human corneal buttons. Riboflavin 0.1% solution was applied before ultraviolet A light treatment and then for every 2 minutes for 30 minutes while the corneas were exposed to ultraviolet A light at a wavelength of 370 nm and intensity of 3 mW/cm(2). Each cornea was evaluated using confocal, electron, and light microscopy.
Confocal microscopy demonstrated normal-appearing corneas on their initial pretreatment examination, with reduced stromal detail. After treatment, a superficial layer of highly reflective spherical structures (4-10 microm) was observed. Many of these hyperreflective structures appeared up to a depth of 300 microm. The remainder of the corneal stroma and endothelium appeared normal. Electron microscopy showed keratocyte apoptotic changes to a depth of 300 microm. No observable pathologic changes were seen on histology.
Based on clinical studies, corneal cross-linking is a promising treatment that appears to be safe and to halt ectatic corneal disease progression. Initial European studies used animal models to extrapolate human protocols. In conjunction with clinical studies, we believe that human ex vivo corneal studies provide a means to evaluate the structural and morphological changes associated with this procedure, within human corneas, in a manner that cannot be accomplished in vivo.
本研究的目的是使用共聚焦显微镜、电子显微镜和光学显微镜,评估角膜胶原交联在人离体角膜中引起的形态学变化。
从人离体角膜植片中部分去除中央上皮。在紫外线A光治疗前应用0.1%核黄素溶液,然后在角膜暴露于波长为370nm、强度为3mW/cm²的紫外线A光时,每2分钟应用一次,持续30分钟。使用共聚焦显微镜、电子显微镜和光学显微镜对每个角膜进行评估。
共聚焦显微镜检查显示,在初始预处理检查时角膜外观正常,但基质细节减少。治疗后,观察到一层浅表的高反射球形结构(4-10微米)。许多这些高反射结构出现在深度达300微米处。角膜基质和内皮的其余部分外观正常。电子显微镜显示角膜细胞凋亡变化至300微米深度。组织学检查未见明显病理变化。
基于临床研究,角膜交联是一种有前景的治疗方法,似乎安全且能阻止扩张性角膜疾病的进展。最初的欧洲研究使用动物模型来推断人类治疗方案。结合临床研究,我们认为人离体角膜研究提供了一种方法,能够以在体内无法实现的方式评估与该手术相关的人类角膜结构和形态变化。